id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0016-0027,FDA,FDA-1975-N-0016,Proposal To Establish a Monograph for OTC Topical Antimicrobial Products: Page ( 1-100 ),Proposed Rule,Notice of Proposed Rulemaking (NPRM),2016-06-16T04:00:00Z,2016,6,2016-06-16T04:00:00Z,,2017-10-17T17:58:56Z,,0,0,09000064805c1f9d
FDA-1975-N-0016-0026,FDA,FDA-1975-N-0016,Citizen Petition from Procter and Gamble Company,Other,Citizen Petition,2011-08-19T04:00:00Z,2011,8,2011-08-19T04:00:00Z,,2017-10-19T18:27:36Z,,0,0,09000064805c2093
FDA-1975-N-0016-0021,FDA,FDA-1975-N-0016,Letter from FDA CDER to Ciba-Geigy Corporation,Other,Letter(s),1994-07-08T04:00:00Z,1994,7,,,2017-09-25T19:36:18Z,,0,0,09000064805c2277
FDA-1975-N-0016-0020,FDA,FDA-1975-N-0016,"Letter from FDA CDER to Johnson & Johnson Products, Inc.",Other,Letter(s),1994-03-30T05:00:00Z,1994,3,,,2017-09-25T19:34:21Z,,0,0,09000064805c2275